Clinical Trial Update: Memantine and Intensive Speech-Language Therapy in Aphasia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating memantine in combination with intensive speech-language therapy for aphasia after stroke has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphasia
• Stroke

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Gabinete Berthier y Martínez | Conditions: Aphasia, Stroke | Phase 4 | Status: COMPLETED